PROGRAM FACULTY

Michael Crotty, MD, BCh, BAO, MICGP, IMRCS, MCFPC
GP & Obesity Medicine Specialist
Co-Founder & Clinical Lead
My Best Weight Clinic
Dublin, Ireland

Fatima Cody Stanford, MD, MPH, MPA, MBA, FAAP, FACP, FAHA, FAMWA, FTOS
Associate Professor of Medicine and Pediatrics
Obesity Medicine Physician-Scientist
Massachusetts General Hospital
Harvard Medical School
Boston, MA

PROGRAM OVERVIEW

This Immersive Simulation experience aims to increase the use of recommended diagnostic and treatment strategies for obesity in the specialist and primary care settings and engage patients in shared decision-making when devising weight reduction strategies, ultimately improving the health outcomes of patients with obesity.

TARGET AUDIENCE

This educational activity is intended for obesity specialists, endocrinologists, primary care physicians and nurses on a global level, particularly in Germany, Italy, Spain, France, China, Japan, Brazil, UAE, and Saudi Arabia.

LEARNING OBJECTIVES

Upon the completion of this program, attendees should be able to:

• Explain the biological mechanisms that defend body weight and encourage weight regain following diet-induced weight loss
• Provide evidence-based diagnosis and treatment for patients with obesity based on up-to-date guidelines and clinical data
• Compare the safety and efficacy of established and emerging antiobesity medications
• Engage patients in shared decision making when selecting weight reduction strategies

JOINT ACCREDITATION STATEMENT

In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

PHYSICIAN CREDIT DESIGNATION STATEMENT

Med Learning Group designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.

EACCME CREDIT DESIGNATION STATEMENT (For EU Learners)

The AMA (American Medical Association) and UEMS (European Union of Medical Specialists) have an agreement of mutual recognition of Continuing Medical Education (CME) credits with the European Union of Medical Specialists (UEMS), the accreditation body for European countries. Physicians interested in converting AMA PRA Category 1 Credit^TM to UEMS-European Accreditation Council for Continuing Medical Education CME credits (ECMECs) should contact the UEMS at mutualrecognition@uems.eu.

NURSES (ANCC) CREDIT DESIGNATION

Med Learning Group designates this activity for a maximum of 1.0 ANCC contact hour.

COMMISSION ON DIETETIC REGISTRATION

Med Learning Group designates this activity for a maximum of 1.0 CPEU.

SCOPE ACCREDITATION

This course is SCOPE Accredited for providing exceptional education standards, with content based on the latest evidence and free of commercial bias. It has been reviewed and independently validated by the World Obesity Federation’s (WOF) Clinical Care Committee. WOF designates this activity for a maximum of 0.5 SCOPE points.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS

All relevant financial relationships have been mitigated.

Content Review

The content of this activity was independently peer reviewed by a physician and nurse reviewer.

Individuals in Control of the Content of the Activity

The individuals in control of the content of this activity have reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CE activity:

• Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
• Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
• M Susan Burke, MD, has nothing to disclose.
• Sarah Milano, RN, MSN, has nothing to disclose.
• A medical reviewer from CME Peer Review LLC, has nothing to disclose.
• Danielle Cimorelli, ASN, has nothing to disclose.
• Nicole Longo, DO, FACOI, VP Med/Sci Services & Learner Engagement for Med Learning Group, has nothing to disclose.
• Lisa Kuhns, PhD, Medical Director for Med Learning Group, has nothing to disclose.
• Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
• Jessica McMullen, MPH, Senior Program Manager for Med Learning Group, has nothing to disclose.
• Laura Aibara, Program Coordinator for Med Learning Group, has nothing to disclose.
• Aimee Meissner, Accreditation and Outcomes Coordinator, has nothing to disclose.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.

METHOD OF PARTICIPATION

There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.

DISCLAIMER

Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision making before applying any information, whether provided here or by others, for any professional use.

For CE questions, please contact Med Learning Group at info@medlearninggroup.com

Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at info@medlearninggroup.com

RELEASED DATE: April 30, 2024
EXPIRATION DATE: April 30, 2025